IRIS
MARCHETTI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 921
EU - Europa 419
AS - Asia 243
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 920
IE - Irlanda 224
SG - Singapore 107
CN - Cina 90
DE - Germania 56
UA - Ucraina 51
TR - Turchia 29
SE - Svezia 23
CZ - Repubblica Ceca 18
BE - Belgio 17
IT - Italia 12
VN - Vietnam 12
FR - Francia 8
FI - Finlandia 5
GB - Regno Unito 4
IN - India 2
JP - Giappone 2
AR - Argentina 1
CA - Canada 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
NZ - Nuova Zelanda 1
Totale 1.586
Salva come PNG Salva come JPEG
Città #
Dublin 224
Chandler 208
Jacksonville 173
Singapore 95
Santa Clara 60
Ann Arbor 53
New York 53
Boardman 47
Beijing 29
Lawrence 29
Princeton 29
Ashburn 28
Izmir 23
Wilmington 20
Brno 18
Brussels 17
Bremen 12
Dong Ket 12
Munich 12
Dearborn 10
Los Angeles 8
San Mateo 8
Nanchang 7
Nanjing 6
Seattle 6
Shanghai 5
Woodbridge 4
Des Moines 3
Guangzhou 3
Helsinki 3
Ningbo 3
Taizhou 3
Tianjin 3
Baotou 2
Dallas 2
Houston 2
Jiaxing 2
Lanzhou 2
Norwalk 2
Pune 2
San Francisco 2
Tokyo 2
Wuxi 2
Anyang 1
Bellante 1
Berlin 1
Buenos Aires 1
Changsha 1
Chieti 1
Clifton 1
Edinburgh 1
Frankfurt am Main 1
Grosseto 1
Guiyang 1
Hangzhou 1
Hebei 1
Istanbul 1
Kunming 1
L'aquila 1
Marseille 1
Nuremberg 1
Paris 1
Shenyang 1
Stockholm 1
Taiyuan 1
Tel Aviv 1
Toronto 1
Verona 1
Wellington 1
Totale 1.260
Salva come PNG Salva come JPEG
Nome #
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 73
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 71
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 67
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 66
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 65
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 64
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 62
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 62
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 62
Factors influencing the clinical presentation of breakthrough pain in cancer patients 61
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 60
Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study 59
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 58
Evaluation of prognostic factors for survival in transverse colon cancer 57
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 56
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 55
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 54
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 53
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 50
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 49
What cancer patients actually know regarding Medical Cannabis? A cross-sectional survey with a critical analysis of the current attitudes 48
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program 45
Integration between oncology and palliative care: Does one size fit all? 45
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 45
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 45
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 44
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 41
Is it possible to teach pain therapy playing basketball? 40
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 38
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 37
Totale 1.632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.921
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020156 0 0 0 0 0 10 61 5 35 16 2 27
2020/2021227 4 31 2 28 29 4 29 8 35 4 40 13
2021/2022110 3 3 7 5 11 0 2 11 10 3 16 39
2022/2023612 37 51 3 80 34 64 0 32 280 4 20 7
2023/2024185 13 12 4 12 15 78 0 7 0 7 7 30
2024/2025247 23 9 44 39 83 49 0 0 0 0 0 0
Totale 1.632